$1.28
0.00% today
Nasdaq, Nov 20, 10:01 pm CET

Fluidigm Corporation Stock price

$1.28
+0.00 0.00% 1M
+0.23 21.90% 6M
-0.47 26.86% YTD
-0.23 15.23% 1Y
-0.07 5.19% 3Y
-5.00 79.62% 5Y
-8.77 87.26% 10Y
-12.74 90.87% 20Y
Nasdaq, Closing price Wed, Nov 19 2025
+0.04 3.23%

Key metrics

Basic
Market capitalization
$492.2m
Enterprise Value
$297.6m
Net debt
positive
Cash
$194.9m
Shares outstanding
383.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.8 | 5.6
EV/Sales
2.3 | 3.4
EV/FCF
negative
P/B
1.2
Financial Health
Equity Ratio
77.1%
Return on Equity
-39.2%
ROCE
-24.8%
ROIC
-38.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$128.8m | $87.2m
EBITDA
$-93.6m | $-57.8m
EBIT
$-107.2m | $-98.3m
Net Income
$-128.3m | $-85.2m
Free Cash Flow
$-98.4m
Growth (TTM | estimate)
Revenue
-17.4% | -50.0%
EBITDA
9.3% | 51.0%
EBIT
10.6% | 27.0%
Net Income
24.8% | 53.9%
Free Cash Flow
33.7%
Margin (TTM | estimate)
Gross
47.9%
EBITDA
-72.6% | -66.3%
EBIT
-83.2%
Net
-99.6% | -97.7%
Free Cash Flow
-76.4%
More
EPS
$-0.3
FCF per Share
$-0.3
Short interest
4.7%
Employees
816
Rev per Employee
$210.0k
Show more

Is Fluidigm Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Fluidigm Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Fluidigm Corporation forecast:

4x Buy
57%
3x Hold
43%

Analyst Opinions

7 Analysts have issued a Fluidigm Corporation forecast:

Buy
57%
Hold
43%

Financial data from Fluidigm Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
129 129
17% 17%
100%
- Direct Costs 67 67
16% 16%
52%
62 62
18% 18%
48%
- Selling and Administrative Expenses 131 131
7% 7%
102%
- Research and Development Expense 38 38
31% 31%
29%
-94 -94
9% 9%
-73%
- Depreciation and Amortization 14 14
19% 19%
11%
EBIT (Operating Income) EBIT -107 -107
11% 11%
-83%
Net Profit -128 -128
25% 25%
-100%

In millions USD.

Don't miss a Thing! We will send you all news about Fluidigm Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fluidigm Corporation Stock News

Neutral
Business Wire
one day ago
LOS ANGELES & SAN FRANCISCO--(BUSINESS WIRE)-- #Biotech--MI & Standard BioTools integrate HCR™ Gold with the Hyperion™ Imaging System to enable amplified RNA and protein detection for Imaging Mass Cytometry.
Neutral
PRNewsWire
10 days ago
Following global commercial launch in September, Illumina Protein Prep's "out of the box" solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed Sydney Mass Spectrometry is the first facility in the wider Asia Pacific region to offer Illumina Protein Prep, adding to a growing list of institutions revealing biological insights with exception...
Neutral
GlobeNewsWire
16 days ago
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended September 30, 2025.
More Fluidigm Corporation News

Company Profile

Fluidigm Corp. is engaged in the development, manufacture and marketing of biotechnology tools fro life sciences research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics; and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen R. Quake and Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Head office United States
CEO Michael Egholm
Employees 816
Founded 1999
Website www.standardbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today